company background image
STMN

Straumann Holding SWX:STMN Stock Report

Last Price

CHF110.15

Market Cap

CHF17.6b

7D

9.7%

1Y

-26.3%

Updated

25 Jun, 2022

Data

Company Financials +
STMN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance6/6
Financial Health5/6
Dividends0/6

STMN Stock Overview

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide.

Straumann Holding Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Straumann Holding
Historical stock prices
Current Share PriceCHF110.15
52 Week HighCHF210.80
52 Week LowCHF97.26
Beta1.05
1 Month Change-1.03%
3 Month Change-22.07%
1 Year Change-26.30%
3 Year Change27.87%
5 Year Change101.93%
Change since IPO5,132.78%

Recent News & Updates

Jun 23
Straumann Holding (VTX:STMN) Could Easily Take On More Debt

Straumann Holding (VTX:STMN) Could Easily Take On More Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

May 26
Should You Be Adding Straumann Holding (VTX:STMN) To Your Watchlist Today?

Should You Be Adding Straumann Holding (VTX:STMN) To Your Watchlist Today?

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...

May 12
Is Straumann Holding AG (VTX:STMN) Potentially Undervalued?

Is Straumann Holding AG (VTX:STMN) Potentially Undervalued?

Let's talk about the popular Straumann Holding AG ( VTX:STMN ). The company's shares received a lot of attention from a...

Shareholder Returns

STMNCH Medical EquipmentCH Market
7D9.7%6.1%3.4%
1Y-26.3%-10.8%-12.4%

Return vs Industry: STMN underperformed the Swiss Medical Equipment industry which returned -10.8% over the past year.

Return vs Market: STMN underperformed the Swiss Market which returned -12.4% over the past year.

Price Volatility

Is STMN's price volatile compared to industry and market?
STMN volatility
STMN Average Weekly Movement7.2%
Medical Equipment Industry Average Movement5.7%
Market Average Movement4.5%
10% most volatile stocks in CH Market7.6%
10% least volatile stocks in CH Market2.4%

Stable Share Price: STMN is more volatile than 75% of Swiss stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: STMN's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Swiss stocks.

About the Company

FoundedEmployeesCEOWebsite
19548,873Guillaume Daniellothttps://www.straumann.com

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics.

Straumann Holding Fundamentals Summary

How do Straumann Holding's earnings and revenue compare to its market cap?
STMN fundamental statistics
Market CapCHF17.56b
Earnings (TTM)CHF396.08m
Revenue (TTM)CHF2.02b

44.3x

P/E Ratio

8.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
STMN income statement (TTM)
RevenueCHF2.02b
Cost of RevenueCHF481.88m
Gross ProfitCHF1.54b
Other ExpensesCHF1.14b
EarningsCHF396.08m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Aug 16, 2022

Earnings per share (EPS)2.48
Gross Margin76.17%
Net Profit Margin19.59%
Debt/Equity Ratio32.0%

How did STMN perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

27%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is STMN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for STMN?

Other financial metrics that can be useful for relative valuation.

STMN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue8.6x
Enterprise Value/EBITDA28.2x
PEG Ratio3.1x

Price to Earnings Ratio vs Peers

How does STMN's PE Ratio compare to its peers?

STMN PE Ratio vs Peers
The above table shows the PE ratio for STMN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average25.8x

Price-To-Earnings vs Peers: STMN is expensive based on its Price-To-Earnings Ratio (44.3x) compared to the peer average (25.8x).


Price to Earnings Ratio vs Industry

How does STMN's PE Ratio compare vs other companies in the Medical Equipment Industry?

Price-To-Earnings vs Industry: STMN is expensive based on its Price-To-Earnings Ratio (44.3x) compared to the Swiss Medical Equipment industry average (38x)


Price to Earnings Ratio vs Fair Ratio

What is STMN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

STMN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio44.3x
Fair PE Ratio42.5x

Price-To-Earnings vs Fair Ratio: STMN is expensive based on its Price-To-Earnings Ratio (44.3x) compared to the estimated Fair Price-To-Earnings Ratio (42.5x).


Share Price vs Fair Value

What is the Fair Price of STMN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: STMN (CHF110.15) is trading below our estimate of fair value (CHF155.72)

Significantly Below Fair Value: STMN is trading below fair value by more than 20%.


Price to Earnings Growth Ratio

PEG Ratio: STMN is poor value based on its PEG Ratio (3.1x)


Discover undervalued companies

Future Growth

How is Straumann Holding forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?

Future Growth Score

4/6

Future Growth Score 4/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


14.1%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: STMN's forecast earnings growth (14.1% per year) is above the savings rate (-0.3%).

Earnings vs Market: STMN's earnings (14.1% per year) are forecast to grow faster than the Swiss market (6.1% per year).

High Growth Earnings: STMN's earnings are forecast to grow, but not significantly.

Revenue vs Market: STMN's revenue (11.9% per year) is forecast to grow faster than the Swiss market (4.3% per year).

High Growth Revenue: STMN's revenue (11.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: STMN's Return on Equity is forecast to be high in 3 years time (25.4%)


Discover growth companies

Past Performance

How has Straumann Holding performed over the past 5 years?

Past Performance Score

6/6

Past Performance Score 6/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


1.3%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: STMN has high quality earnings.

Growing Profit Margin: STMN's current net profit margins (19.6%) are higher than last year (6.4%).


Past Earnings Growth Analysis

Earnings Trend: STMN's earnings have grown by 1.3% per year over the past 5 years.

Accelerating Growth: STMN's earnings growth over the past year (333.9%) exceeds its 5-year average (1.3% per year).

Earnings vs Industry: STMN earnings growth over the past year (333.9%) exceeded the Medical Equipment industry 263%.


Return on Equity

High ROE: STMN's Return on Equity (26.6%) is considered high.


Discover strong past performing companies

Financial Health

How is Straumann Holding's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: STMN's short term assets (CHF1.5B) exceed its short term liabilities (CHF562.6M).

Long Term Liabilities: STMN's short term assets (CHF1.5B) exceed its long term liabilities (CHF905.0M).


Debt to Equity History and Analysis

Debt Level: STMN has more cash than its total debt.

Reducing Debt: STMN's debt to equity ratio has increased from 31.5% to 32% over the past 5 years.

Debt Coverage: STMN's debt is well covered by operating cash flow (116.8%).

Interest Coverage: STMN's interest payments on its debt are well covered by EBIT (36.9x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Straumann Holding current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


0.61%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: STMN's dividend (0.61%) isn’t notable compared to the bottom 25% of dividend payers in the Swiss market (1.99%).

High Dividend: STMN's dividend (0.61%) is low compared to the top 25% of dividend payers in the Swiss market (4.14%).


Stability and Growth of Payments

Stable Dividend: STMN is not paying a notable dividend for the Swiss market, therefore no need to check if payments are stable.

Growing Dividend: STMN is not paying a notable dividend for the Swiss market, therefore no need to check if payments are increasing.


Earnings Payout to Shareholders

Earnings Coverage: STMN is not paying a notable dividend for the Swiss market.


Cash Payout to Shareholders

Cash Flow Coverage: STMN is not paying a notable dividend for the Swiss market.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.4yrs

Average management tenure


CEO

Guillaume Daniellot (51 yo)

9.17yrs

Tenure

CHF3,355,000

Compensation

Mr. Guillaume Daniellot has been Chief Executive Officer of Straumann Holding AG since January 1, 2020 and served as its Executive Vice President of Sales for North America until January 1, 2020. Mr. Danie...


CEO Compensation Analysis

Compensation vs Market: Guillaume's total compensation ($USD3.51M) is below average for companies of similar size in the Swiss market ($USD6.61M).

Compensation vs Earnings: Guillaume's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: STMN's management team is considered experienced (2.4 years average tenure).


Board Members

Experienced Board: STMN's board of directors are considered experienced (4.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Straumann Holding AG's employee growth, exchange listings and data sources


Key Information

  • Name: Straumann Holding AG
  • Ticker: STMN
  • Exchange: SWX
  • Founded: 1954
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: CHF17.558b
  • Shares outstanding: 159.40m
  • Website: https://www.straumann.com

Number of Employees


Location

  • Straumann Holding AG
  • Peter Merian-Weg 12
  • Basel
  • Basel-Stadt
  • 4002
  • Switzerland

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/25 00:00
End of Day Share Price2022/06/24 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.